# Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus? - Cureus

*Источник: Cureus*
*Дата: 2026-07-15*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMi3wJBVV95cUxPMm84aGZqdzlrbS00WFJLaDkxVzVIdDBMNTJxWWRocnJuWUt4VkR3dnZ0MnRNNG10LXM2NVNfXzBaLTFubGdEYU1NTnd1ZDhra2xuV2w2QUhiSWxseF83ZmFUbVRQak85UW44d1pFbkN1Y1BOeVR2bkY4YjdqeWhzVmZ0UVN0Qk9qQU95bVRIM2tkTmVjckZCbDVGcE1hQXpjODUwMl9aYUVtdU9pQnNDWEQ4QW40RmdaYkR0eHpNNVZkQVd2QlFHeUstcmlYRnh3dFBuYlhLeVExMW9NbTd5NGZYc0NaQ2pQd3NCb08yUG5wY0FNcGh5RTRlVUFkTzRNMGJ5MHpPb3dkR0NiSWpnTEZpS0laemFfdTdqazI1UDZ2OVhKeklyZThTUHhmYTRfVzY4ZGR3enk5WDBCMHpISUczT1NrYVQ2d2U3M01KZ243WUtvcTJRdTd0alpVaGs?oc=5" target="_blank">Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus?</a>&nbsp;&nbsp;<font color="#6f6f6f">Cureus</font>

[Оригинал](https://www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus)